Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc.verified

SLNO

Price:

$44.945

Market Cap:

$1.94B

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.[Read more]

Industry

Biotechnology

IPO Date

2014-11-13

Stock Exchange

NASDAQ

Ticker

SLNO

The Current Ratio as of December 2024 (TTM) for Soleno Therapeutics, Inc. (SLNO) is 17.26

According to Soleno Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 17.26. This represents a change of -4.94% compared to the average of 18.15 of the last 4 quarters.

Soleno Therapeutics, Inc. (SLNO) Historical Current Ratio (quarterly & annually)

How has SLNO Current Ratio performed in the past?

The mean historical Current Ratio of Soleno Therapeutics, Inc. over the last ten years is 6.41. The current 17.26 Current Ratio has changed 26.80% with respect to the historical average. Over the past ten years (40 quarters), SLNO's Current Ratio was at its highest in in the June 2024 quarter at 29.24. The Current Ratio was at its lowest in in the June 2015 quarter at 0.61.

Quarterly (TTM)
Annual

Average

6.41

Median

5.04

Minimum

2.01

Maximum

14.89

Soleno Therapeutics, Inc. (SLNO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Soleno Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 5.92%

Maximum Annual Current Ratio = 14.89

Minimum Annual Increase = -68.97%

Minimum Annual Current Ratio = 2.01

Quarterly (TTM)
Annual
YearCurrent RatioChange
202314.89596.12%
20222.14-23.59%
20212.80-51.97%
20205.8336.87%
20194.26-67.59%
201813.1426.57%
201710.38366.42%
20162.2310.99%
20152.01-68.97%
20146.465.92%

Soleno Therapeutics, Inc. (SLNO) Average Current Ratio

How has SLNO Current Ratio performed in the past?

The current Current Ratio of Soleno Therapeutics, Inc. (SLNO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

6.61

5-year avg

5.98

10-year avg

6.41

Soleno Therapeutics, Inc. (SLNO) Current Ratio vs. Peers

How is SLNO’s Current Ratio compared to its peers?

Soleno Therapeutics, Inc.’s Current Ratio is greater than Annexon, Inc. (17.18), less than Icosavax, Inc. (18.06), greater than VectivBio Holding AG (9.14), greater than Bolt Biotherapeutics, Inc. (3.16), greater than Lyra Therapeutics, Inc. (3.64), less than Pulmatrix, Inc. (19.40), greater than Capricor Therapeutics, Inc. (0.00), greater than Akari Therapeutics, Plc (0.29), greater than Diffusion Pharmaceuticals Inc. (15.04), greater than Onconova Therapeutics, Inc. (1.07), greater than Catalyst Biosciences, Inc. (3.72), greater than Bio-Path Holdings, Inc. (0.86), greater than Moleculin Biotech, Inc. (2.08), greater than Day One Biopharmaceuticals, Inc. (14.62), greater than Acumen Pharmaceuticals, Inc. (10.43), greater than X4 Pharmaceuticals, Inc. (4.89), greater than Inozyme Pharma, Inc. (7.68), greater than Applied Molecular Transport Inc. (4.99), greater than Aileron Therapeutics, Inc. (3.30), greater than Benitec Biopharma Inc. (15.01),

Build a custom stock screener for Soleno Therapeutics, Inc. (SLNO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Soleno Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Soleno Therapeutics, Inc. (SLNO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Soleno Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Soleno Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Soleno Therapeutics, Inc. (SLNO)?

What is the highest Current Ratio for Soleno Therapeutics, Inc. (SLNO)?

What is the 3-year average Current Ratio for Soleno Therapeutics, Inc. (SLNO)?

What is the 5-year average Current Ratio for Soleno Therapeutics, Inc. (SLNO)?

How does the current Current Ratio for Soleno Therapeutics, Inc. (SLNO) compare to its historical average?